Table 4.
Presence of pathogenic TNFRSF1A mutations and at least one among the following: ▪ Duration of episodes ≥ 7 days ▪ Myalgia ▪ Migratory rash ▪ Periorbital oedema ▪ Relatives affected |
OR | Presence of VUS of TNFRSF1A and at least two among the following: ▪ Duration of episodes ≥ 7 days ▪ Myalgia ▪ Migratory rash ▪ Periorbital oedema ▪ Relatives affected |